Skip to main content

GOLDMAN SACHS GROUP INC

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 886982 NEW YORK, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$52,357,033
-$9,946,398 QoQ
Shares Held
1,544,911
-20.6% QoQ
Ownership
1.29%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 197 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NAMS Over Time

Shares Held

Position Value (USD)

Derivatives in NAMS

reported options exposure · as of Jun 30, 2026
CallValue
$576,130
CallShares
17,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. NAMS ranks #62 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NAMS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $576,130 17,000
2026-06-30 $52,357,033 1,544,911
2026-03-31 $62,303,431 1,946,374
2025-12-31 $60,536,222 1,725,662
2025-09-30 $25,042,898 880,552
2025-06-30 $17,204,137 949,980
2025-03-31 $12,682,454 619,563
2024-12-31 $16,826,047 654,710
2024-09-30 $565,611 34,073
2024-06-30 $487,684 25,387
2024-03-31 $30,353,710 1,283,455
2023-12-31 $15,462,865 1,384,321